One-Pager

Neuro: ICP and Stroke

ICP, herniation, EVD care, osmotics, GCS, stroke and seizures

Reviewed by Alex G, BSN, RN, CEN, CCRN, CMC, NREMT-P · Checked against current sources October 2026

Download one-page PDFLetter landscape, ready to print or keep with your notes

ICP, CPP and the ICP waveform

Thresholds: Brain Trauma Foundation (severe TBI). Many non-TBI protocols treat ICP above 20.
MeasureValue
Normal ICP (adult)Up to about 15 mm Hg
Treat ICP (severe TBI)Above 22 mm Hg
CPPMAP − ICP
CPP target (TBI)60–70 mm Hg
SBP floor (TBI)≥100 at age 50–69; ≥110 at 15–49 or >70

Normal ICP waveform: P1 (percussion) > P2 (tidal) > P3 (dicrotic).

Rising ICP and herniation

Prevention: HOB ≥30°, head midline; no neck or hip flexion or tight ETT ties; brief suctioning; control pain, fever and seizures; SpO2 above 94%; avoid low sodium. Hyperventilation (PaCO2 32–35): brief bridge only.

EVD care and osmotic therapy

Exam ranges; follow your institution's or agency's protocols. Classic exam rule: hold mannitol if osmolality exceeds 320.
AgentTypical adult doseWatch
Mannitol0.25–1 g/kg IV bolusFilter; diuresis, low BP, kidneys, osmolality
3% saline2.5–5 mL/kg bolus or infusionFavored in TBI, ICH; sodium every 4–6 h, keep <160
23.4% saline30 mL over 10–20 minCentral line only

GCS and NIHSS

Glasgow Coma Scale © University of Glasgow. Total 3–15.
ScoreEyeVerbalMotor
6––Obeys commands
5–OrientedLocalizes
4SpontaneousConfusedNormal flexion (withdraws)
3To soundWordsAbnormal flexion
2To pressure (pain)SoundsExtension
1NoneNoneNone

Acute ischemic stroke

Time starts at last known well (LKW), not when found. Check glucose (treat below 60) and get a non-contrast CT or MRI before any lytic.

2026 AHA/ASA guideline. Follow your institution's or agency's protocols.
TherapyWindowKey details
Tenecteplase0–4.5 h0.25 mg/kg IV push, max 25 mg
Alteplase0–4.5 h0.9 mg/kg (max 90): 10% bolus, rest over 1 h
Lytic, extended4.5–9 h or wake-upPerfusion mismatch, or MRI DWI–FLAIR mismatch (wake-up)
Thrombectomy0–6 h; selected 6–24 hICA/M1: NIHSS ≥6. Basilar: NIHSS ≥10, to 24 h
SituationBP goal
Before a lyticBelow 185/110
Lytic or thrombectomy, first 24 hBelow 180/105
No reperfusion, ≥220/120Lower about 15% at first
No reperfusion, <220/120No routine lowering for 48–72 h

Hemorrhagic stroke (ICH)

Status epilepticus

Seizure lasting 5 min or more, or repeated seizures without recovery between. Benzodiazepines are often underdosed.

Exam study doses; follow your institution's or agency's protocols.
AccessFirst-line benzodiazepine (adult)
IVLorazepam 0.1 mg/kg, max 4 mg/dose; repeat once in 3–5 min
No IVMidazolam 10 mg IM
IV alternativeDiazepam 0.15 mg/kg, max 10 mg

Check glucose and protect the airway without delaying the benzodiazepine. Still seizing: levetiracetam, fosphenytoin or valproate.

Practice Neuro: ICP and Stroke questions free in your browser101 exam-style questions with rationales. No account or download needed.

In depth

The one-page summary above is what the PDF prints. These sections go further.

Monro-Kellie, compliance, CPP and autoregulation

The skull holds brain (about 80% of its volume), blood (10%) and CSF (10%). By the Monro-Kellie doctrine, added volume (hematoma, edema, hydrocephalus) must push an equal volume out: CSF shifts first into the spinal subarachnoid space, then venous blood leaves through the jugular veins. CSF is made at about 20 mL/h (500 mL/day) against a total of about 150 mL.

Compliance (change in volume ÷ change in pressure) stays high while these buffers last, then collapses: the pressure–volume curve is flat, then steep. On the steep part a few milliliters raise ICP 10–20 mm Hg, so suctioning, coughing or fever can tip a patient into crisis.

CPP = MAP − ICP. Cerebral blood flow is normally about 50 mL/100 g/min; neurons stop signaling below about 20 and infarct below about 10. Intact autoregulation holds flow steady across a CPP of roughly 50–150 mm Hg, shifted right by chronic hypertension. After TBI, SAH or ICH it often fails: flow becomes pressure-passive, low CPP causes ischemia and high CPP adds hyperemia and edema. A positive pressure reactivity index (PRx, the moving MAP–ICP correlation) signals failed autoregulation and can define an individual optimal CPP. Zero the arterial line at one documented level (tragus in a 2015 UK consensus, phlebostatic axis in many US units); at 30° they differ by 10 mm Hg or more.

FactorEffect on blood flow and ICP
PaCO₂CBF changes about 3% per mm Hg (PaCO₂ 20–80)
PaO₂Little effect until below 50–60, then CBF rises steeply
TemperatureMetabolism changes about 7% per °C; fever raises ICP
Venous outflowHead turned, tight ties, coughing, high PEEP raise ICP

ICP monitors and the ICP waveform

DeviceStrengthsLimits
EVD (ventriculostomy)Reference standard; drains CSF; re-zeroableHighest infection risk; hard with small ventricles
Intraparenchymal sensorEasy to place; low infectionZeroed once before insertion; drifts; no drainage
PbtO₂ probeTissue O₂, normal 25–35 mm HgFocal; reads only tissue near the tip

EVD placement shows new hemorrhage on CT in about 6% but clinically significant bleeding in under 1% (Binz 2009 meta-analysis). SIBICC (2020) treats PbtO₂ below 20 by raising CPP, FiO₂ or hemoglobin; outcome benefit is unproven.

Each beat gives three peaks: P1 (percussion), the arterial pulse from the choroid plexus; P2 (tidal), reflecting brain compliance; P3 (dicrotic), aortic valve closure. Normally P1 > P2 > P3. When P2 equals or exceeds P1 the trace rounds off: compliance is poor even if the mean is under 20. A flat trace with no peaks points to a kinked, clotted or air-filled system, not a real fall in ICP.

Lundberg wavePatternMeaning
A (plateau)ICP 50–100 for 5–20 min, then fallsAlways pathological; exhausted compliance
BRhythmic rises 0.5–2 per minLow compliance; may precede A waves
CSmall oscillations 4–8 per minArterial rhythm; little meaning

EVD management: leveling, drainage, clamping, infection

Zero the transducer and set the drip chamber at the same point: the tragus as the landmark for the foramen of Monro (BTF describes the midbrain; follow one unit standard). Drain height is ordered in cm H₂O above it, commonly 10–20. CSF drains only when ICP exceeds that height; 1 mm Hg = 1.36 cm H₂O, so 20 cm H₂O lets ICP reach about 15 mm Hg.

Orders specify open drainage at a set height, with ICP read by clamping briefly, or a clamped drain opened above an ICP threshold. An open drain's number mostly reflects chamber height. Many protocols want a report above about 20–25 mL/h or when drainage stops. Overdrainage can tear bridging veins (subdural hematoma), rebleed an unsecured aneurysm, or cause upward herniation with a posterior fossa mass.

ProblemCheckAction
No drainage, damped waveformClamps, stopcocks, kinks, heightLower chamber only if protocol allows; call
Sudden high outputHOB or bed height changedClamp, re-level, reopen, report
ICP high with drain openPatency; pain, agitation, fever, seizureRe-level; treat cause; follow tier orders
Catheter pulled outNeuro examClamp, cover site sterilely, call now

Ventriculitis complicates roughly 5–10% of drains; risk rises with IVH or SAH, CSF leak, frequent access and days in place. The NCS 2016 EVD consensus recommends antimicrobial-impregnated catheters, one periprocedural antibiotic dose rather than continuous prophylaxis, CSF sampling only when clinically indicated, and no routine catheter exchange. Blood and fever are common anyway, so watch trends: falling CSF glucose, rising protein, a rising cell index, positive Gram stain or culture. Empiric therapy (IDSA 2017): vancomycin plus cefepime, ceftazidime or meropenem.

Weaning: raise the drain in steps or clamp for about 24 h while ICP, exam and CT are followed; failure means shunt-dependent hydrocephalus. Rapid clamping matched gradual weaning for shunt rates (Klopfenstein 2004). After removal, watch for CSF leak.

Neuro assessment and herniation syndromes

Use a graded stimulus: voice, touch, then pressure. Central pressure (trapezius, supraorbital notch) tests localization; nail-bed pressure tests flexion. A patient localizes when the hand crosses midline or rises above the clavicle toward the stimulus. Score the best motor response but record each side, because asymmetry localizes. The FOUR score (0–16) has no verbal part and suits intubated patients. Record pupil size in mm and reactivity; an oval or newly sluggish pupil can be the first sign of third-nerve compression. A pupillometer NPi below 3 is abnormal.

SyndromeMechanismSigns
SubfalcineCingulate gyrus under the falxMidline shift; ACA compression, opposite leg weak
UncalMedial temporal lobe over the tentoriumSame-side dilated pupil, ptosis; opposite weakness
Central (downward)Diencephalon and midbrain pushed downSmall, then midposition fixed pupils; posturing
UpwardPosterior fossa mass pushes upSmall pupils, downgaze; worse when EVD drains
TonsillarTonsils into the foramen magnumCushing triad, apnea, arrest

In uncal herniation the opposite cerebral peduncle can hit the tentorium (Kernohan notch), giving weakness on the same side as the blown pupil. Central herniation progresses through Cheyne-Stokes, central neurogenic hyperventilation, apneustic and ataxic breathing, and can cause diabetes insipidus. After craniectomy, a sunken flap with decline when upright or after lumbar drainage is paradoxical herniation: lay flat, give fluids, stop lumbar drainage.

TBI and tiered ICP therapy

A single SBP below 90 or PaO₂ below 60 roughly doubled mortality (Traumatic Coma Data Bank). Tranexamic acid within 3 h helped mild to moderate TBI only (CRASH-3, 2019).

BTF 4th editionRecommendation
ICPTreat above 22 mm Hg; monitor in severe TBI
CPP60–70; avoid fluids and pressors to push above 70
SBP≥100 at age 50–69; ≥110 at 15–49 or over 70
HyperventilationNo prophylactic PaCO₂ ≤25; avoid in the first 24 h
Seizure prophylaxisPhenytoin for early (7-day) seizures only
Steroids, hypothermiaNot recommended (CRASH: steroids raised mortality)
CraniectomyLarge flap (≥12 × 15 cm); bifrontal not for outcome

SIBICC (2019) tiers ICP care; treatments within a tier are not ranked.

  1. Tier 0: ICU, intubation, HOB 30–45°, analgesia and sedation, prevent fever, CPP ≥60, Hb above 7, SpO₂ ≥94%, avoid low sodium.
  2. Tier 1: CPP 60–70, deeper sedation, PaCO₂ 35–38, mannitol or hypertonic saline boluses, CSF drainage, consider EEG.
  3. Tier 2: PaCO₂ 32–35, neuromuscular blockade if a test dose works, MAP challenge to test autoregulation, then raise CPP if intact.
  4. Tier 3: barbiturate coma if a test dose works, secondary decompressive craniectomy, mild hypothermia (35–36 °C).

SIBICC avoids continuous mannitol, lumbar drainage, PaCO₂ below 30 and steroids. Pentobarbital (classic regimen 10 mg/kg over 30 min, 5 mg/kg/h for 3 h, then 1 mg/kg/h to burst suppression) causes hypotension, ileus, immunosuppression and hypothermia, and can leave pupils small and unreactive.

Follow your institution's protocols; mannitol's label dose starts at 0.25 g/kg.
Osmotic agentDose (ENLS v6)Monitor
Mannitol 20%0.5–1 g/kg over 5–15 min; in-line filterOsmolar gap, BP, urine output, creatinine
3% saline250 mL or 2.5–5 mL/kg bolusSodium every 4–6 h; chloride
23.4% saline30 mL over 10–20 min, central lineSodium; hypotension if pushed fast

Mannitol first expands plasma and lowers viscosity, triggering reflex arteriolar constriction within minutes, then draws water from brain over 15–30 min; the effect lasts about 1.5–6 h. Replace its diuresis with isotonic fluid. Redose when the osmolar gap is below about 20; holding at osmolality 320 does not predict kidney injury (NCS 2020) but is still the exam answer. Hypertonic saline expands volume and suits hypotensive patients. Protocols cap sodium at 155–160, use acetate blends against hyperchloremic acidosis, and wean slowly to avoid rebound edema.

Aneurysmal subarachnoid hemorrhage

ScaleBased onGrades
Hunt and HessClinical: headache to deep comaI–V; IV–V poor grade
WFNSGCS plus focal motor deficitI (GCS 15) to V (GCS 3–6)
Modified FisherCT clot thickness and IVH0–4; 3–4 highest vasospasm risk

Rebleeding peaks in the first 24 h. Until the aneurysm is secured, treat pain, reverse anticoagulants, place an EVD for hydrocephalus and avoid hypertension; most centers keep SBP below 140–160, and the 2023 AHA/ASA guideline sets no single number. Secure the aneurysm early, ideally within 24 h (2023 AHA/ASA), by coiling or clipping; ISAT (2002) favored coiling when both were possible.

Angiographic vasospasm appears in about 70% in classic series, mostly days 3–14, with risk peaking at days 6–10 (AHA/ASA 2023); about 30% develop delayed cerebral ischemia (DCI): a new focal deficit or GCS drop of 2 or more for at least 1 h with no other cause. Hourly exams are the main monitor; transcranial Doppler adds MCA mean velocity (above 120 cm/s suggests spasm, above 200 severe) and a Lindegaard ratio above 3. Keep euvolemia; triple-H therapy is abandoned. For DCI, induce hypertension stepwise, then intra-arterial vasodilators or angioplasty. Magnesium, statins and clazosentan did not improve outcome.

Fluid restriction raises DCI risk after SAH.
FeatureCerebral salt wastingSIADHCentral DI
VolumeLowNormalLow or normal
Serum sodiumLowLowHigh
UrineHigh output, high sodiumConcentrated, high sodiumDilute (SG <1.005), high output
TreatmentSaline; fludrocortisoneIn SAH: saline, not restrictionDesmopressin; free water

ICH and ischemic stroke after reperfusion

The ICH score (GCS 3–4 = 2 or 5–12 = 1; volume ≥30 mL; IVH; infratentorial; age ≥80) gave 30-day mortality from 0% at 0 to 72% at 3 (Hemphill 2001). Early limits on care make such scores self-fulfilling (2022 AHA/ASA). Up to a third expand, mostly within 6 h. Priorities: smooth BP control (variability predicts worse outcome), glucose, normothermia, a swallow screen, compression devices from admission (CLOTS 3) and low-dose heparin after 24–48 h. Cerebellar ICH with decline, brainstem compression or hydrocephalus needs evacuation. Minimally invasive evacuation of lobar ICH improved function in ENRICH (2024).

After a lytic, symptomatic hemorrhage occurs in about 6% (6.4% with alteplase in NINDS) and orolingual angioedema in about 1–5%, more with ACE inhibitors. After thrombectomy, check the access site and distal pulses with each neuro check; back or flank pain with hypotension suggests retroperitoneal bleeding. Keep BP below 180/105 for 24 h; the 2026 AHA/ASA guideline rates an SBP target below 140 after successful thrombectomy as harmful.

Large MCA infarcts swell most on days 2–5. Hemicraniectomy within 48 h in patients 60 or younger cut mortality from about 71% to 22% (pooled DECIMAL, DESTINY, HAMLET); over 60 (DESTINY II) it lowered mortality but most survivors were severely disabled. Keep glucose 140–180.

Seizures, cEEG, prognosis after arrest and brain death

In Claassen 2004, 19% of ICU patients on continuous EEG had seizures, 92% purely electrographic; comatose patients often needed 48 h of recording. ACNS 2021 defines electrographic status as 10 continuous minutes, or 20% of any hour, of seizure activity. Paralyzed patients need cEEG to show seizures at all.

In ESETT (2019) levetiracetam 60 mg/kg (max 4,500 mg), fosphenytoin 20 mg PE/kg (max 1,500) and valproate 40 mg/kg (max 3,000) each stopped status in about half. Give fosphenytoin no faster than 150 mg PE/min on a cardiac monitor. Refractory status needs midazolam, propofol, ketamine or pentobarbital infusions titrated on cEEG for 24–48 h, then a slow wean.

After cardiac arrest, prognosticate no earlier than 72 h after ROSC, and only after sedatives, blockers, hypothermia and metabolic derangement are excluded (AHA 2020, ERC-ESICM 2021). ERC-ESICM 2021 considers poor outcome likely when a patient with a motor score of 3 or less at 72 h has two or more of: absent pupillary and corneal reflexes, bilaterally absent N20 SSEP, a highly malignant EEG after 24 h, NSE above 60 µg/L at 48–72 h, status myoclonus within 72 h, or diffuse anoxic injury on CT or MRI.

The 2023 AAN/AAP/CNS/SCCM guideline sets one brain death standard for adults and children. Prerequisites: a known irreversible cause, 24 h or more after a hypoxic-ischemic injury, core temperature ≥36 °C, SBP ≥100 and MAP ≥75 (MAP alone on VA-ECMO), drugs cleared, four twitches on train-of-four, and metabolic disorders corrected. The exam shows coma, non-reactive pupils, and absent corneal, oculocephalic, oculovestibular (50 mL ice water per ear), gag and cough reflexes. One exam suffices in adults; children need two.

Evidence and controversies

TrialFindingWhat changed
BEST-TRIP (2012)324 severe TBI: ICP-guided care no better than exam and CTMonitoring needs a protocol; led to SIBICC
DECRA (2011)155 diffuse TBI: early bifrontal DC, worse 6-mo outcomeBifrontal DC not advised for outcome
RESCUEicp (2016)408 TBI, ICP >25: DC mortality 27% vs 49%; more vegetativeLast-tier DC after a goals talk
INTERACT2 (2013)2,839 ICH: SBP <140 vs <180, primary p=0.06; better mRSSBP target about 140 in ICH
ATACH-2 (2016)1,000 ICH: SBP 110–139 no better; more kidney injuryAvoid SBP below 130
COBI (2021)370 TBI: continuous 20% saline, no 6-month benefitBolus osmotics, not infusions
TTM2 (2021)33 °C vs normothermia: same 6-month mortalityFever prevention after arrest

BEST-TRIP is often misread: its control arm used a strict exam-and-CT protocol, so it showed that monitoring without a treatment plan adds nothing. DECRA operated after 15 minutes of ICP above 20; RESCUEicp waited longer, and at 12 months showed more upper severe disability or better (45% vs 32%).

Unsettled: the ICP threshold (BTF's 22 came from one cohort), individualized CPP from PRx, whether PbtO₂-guided care improves outcome, mannitol versus hypertonic saline, the EVD reference point, and whether to cluster or space nursing care in low compliance.

Exam pearls

Practice free in your browser3,800+ exam-style questions with rationales. No account, no ads. Also free on the App Store and Google Play.

Related one-pagers

Calculators for this topic

Sources

  1. Prabhakaran S, Gonzalez NR, Zachrison KS, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2026;57. doi:10.1161/STR.0000000000000513 Link
  2. UIC Drug Information Group. What are major pharmacotherapy updates from the 2026 AHA/ASA stroke guidelines? April 2026. Link
  3. Greenberg SM, Ziai WC, Cordonnier C, et al. 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2022;53:e282–e361. Link
  4. emDocs. Intracerebral Hemorrhage 2022 Guideline Update. Link
  5. Farkas J, et al. EMCrit 326: NeuroEMCrit – 2022 Spontaneous Intracerebral Hemorrhage (ICH) Guidelines. Link
  6. Vallejo MC, Kennedy LS, Dengler B, et al. Treatment of Antithrombotic-Associated Intracranial Hemorrhage in Adults: A Focused Guideline Update from the Neurocritical Care Society and the Society of Critical Care Medicine. Neurocrit Care. Published online September 24, 2026. doi:10.1007/s12028-026-02601-4 (PMID 42786382) Link
  7. AABB. AstraZeneca Withdraws Factor Xa Reversal Agent From U.S. Market. December 23, 2025. Link
  8. Carney N, Totten AM, O'Reilly C, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Brain Trauma Foundation. Neurosurgery. 2017;80(1):6–15. Link
  9. Bhalla P, Dingman JS, Aysenne A. Emergency Neurological Life Support: Intracranial Hypertension and Herniation Protocol, Version 6.0. Neurocritical Care Society; updated September 2024. Link
  10. Emergency Neurological Life Support: Intracranial Hypertension and Herniation Protocol, Version 4.0. Neurocritical Care Society. Link
  11. Cook AM, Morgan Jones G, Hawryluk GWJ, et al. Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients. Neurocrit Care. 2020;32:647–666. Link
  12. Tripathy S, Ahmad SR. Raised Intracranial Pressure Syndrome: A Stepwise Approach. Indian J Crit Care Med. 2019;23(Suppl 2). Link
  13. Bianchini L, de Matos PMPG, Roepke RML, Besen BAMP. Management of intracranial hypertension with and without invasive intracranial pressure monitoring. World J Crit Care Med. 2025;14(3):105645. doi:10.5492/wjccm.v14.i3.105645 Link
  14. Merck Manual Professional Version. Brain Herniation. Link
  15. Mannitol Injection prescribing information. Hospira, Inc. (DailyMed), revised May 2025. Link
  16. Mathur R, et al. Evolving concepts in intracranial pressure monitoring: from traditional monitoring to precision medicine. Neurotherapeutics. 2025. Link
  17. Vieira TW, Sakamoto VTM, Araujo BR, et al. External Ventricular Drains: Development and Evaluation of a Nursing Clinical Practice Guideline. Nurs Rep. 2022. Link
  18. American Association of Neuroscience Nurses. A Nurse's Guide to Maintaining External Ventricular Drains. Link
  19. Glasgow Coma Scale. University of Glasgow and Sir Graham Teasdale. Assessment and permissions pages. Link
  20. StrokEngine. National Institutes of Health Stroke Scale (NIHSS). Link
  21. Swor DE, Waybright RA. Emergency Neurological Life Support: Status Epilepticus Protocol, Version 6.0. Neurocritical Care Society; updated July 2024. Link
  22. Glauser T, Shinnar S, Gloss D, et al. Evidence-Based Guideline: Treatment of Convulsive Status Epilepticus in Children and Adults. American Epilepsy Society. Epilepsy Curr. 2016;16(1):48–61. Link
  23. Genentech. FDA Approves Genentech's TNKase in Acute Ischemic Stroke. Press release, March 3, 2025. Link
  24. Brown C, Clark D III, Jones DW. Updates in the 2025 AHA/ACC Hypertension Guideline. Curr Hypertens Rep. 2026;28(1):19. Link